Is Phibro Animal Stock a Good Investment?
Phibro Animal Investment Advice | PAHC |
- Examine Phibro Animal's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Phibro Animal's leadership team and their track record. Good management can help Phibro Animal navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Phibro Animal's business and its evolving consumer preferences.
- Compare Phibro Animal's performance and market position to its competitors. Analyze how Phibro Animal is positioned in terms of product offerings, innovation, and market share.
- Check if Phibro Animal pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Phibro Animal's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Phibro Animal Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Phibro Animal Health is a good investment.
Sell | Buy |
Buy
Market Performance | Modest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Phibro Animal Stock
Researching Phibro Animal's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The book value of Phibro Animal was at this time reported as 6.38. The company has Price/Earnings To Growth (PEG) ratio of 1.66. Phibro Animal Health last dividend was issued on the 27th of November 2024.
To determine if Phibro Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Phibro Animal's research are outlined below:
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 32.31 subject to Rule 16b-3 |
Phibro Animal Quarterly Cost Of Revenue |
|
Phibro Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Phibro Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Phibro Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of September 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Phibro Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Phibro Animal's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-02-08 | 2022-12-31 | 0.3 | 0.34 | 0.04 | 13 | ||
2022-02-09 | 2021-12-31 | 0.33 | 0.37 | 0.04 | 12 | ||
2021-11-02 | 2021-09-30 | 0.29 | 0.25 | -0.04 | 13 | ||
2020-11-04 | 2020-09-30 | 0.23 | 0.27 | 0.04 | 17 | ||
2020-05-07 | 2020-03-31 | 0.34 | 0.38 | 0.04 | 11 | ||
2017-02-06 | 2016-12-31 | 0.35 | 0.39 | 0.04 | 11 | ||
2024-02-07 | 2023-12-31 | 0.28 | 0.33 | 0.05 | 17 | ||
2023-05-03 | 2023-03-31 | 0.34 | 0.29 | -0.05 | 14 |
Know Phibro Animal's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Phibro Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Phibro Animal Health backward and forwards among themselves. Phibro Animal's institutional investor refers to the entity that pools money to purchase Phibro Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Castleknight Management Lp | 2024-09-30 | 366.6 K | Nuveen Asset Management, Llc | 2024-06-30 | 346.6 K | Amvescap Plc. | 2024-06-30 | 289.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 268.4 K | Bank Of New York Mellon Corp | 2024-06-30 | 246.8 K | Sofinnova Ventures | 2024-06-30 | 237 K | Northern Trust Corp | 2024-09-30 | 228.7 K | Goldman Sachs Group Inc | 2024-06-30 | 226.9 K | Globeflex Capital, L.p. | 2024-09-30 | 204.9 K | Blackrock Inc | 2024-06-30 | 3.5 M | Vanguard Group Inc | 2024-09-30 | 1.5 M |
Phibro Animal's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 961.15 M.Market Cap |
|
Phibro Animal's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Equity | 0.01 | 0.01 |
Determining Phibro Animal's profitability involves analyzing its financial statements and using various financial metrics to determine if Phibro Animal is a good buy. For example, gross profit margin measures Phibro Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Phibro Animal's profitability and make more informed investment decisions.
Phibro Animal's Earnings Breakdown by Geography
Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.
Evaluate Phibro Animal's management efficiency
Phibro Animal Health has return on total asset (ROA) of 0.0526 % which means that it generated a profit of $0.0526 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0655 %, meaning that it created $0.0655 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to 0. In addition to that, Return On Capital Employed is expected to decline to 0.07. At present, Phibro Animal's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.66, whereas Total Assets are forecasted to decline to about 568.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.34 | 6.65 | |
| Tangible Book Value Per Share | 3.88 | 4.07 | |
| Enterprise Value Over EBITDA | 16.58 | 17.41 | |
| Price Book Value Ratio | 2.69 | 3.21 | |
| Enterprise Value Multiple | 16.58 | 17.41 | |
| Price Fair Value | 2.69 | 3.21 |
Examining the leadership quality of Phibro Animal Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield 0.0202 | Forward Dividend Yield 0.0202 | Forward Dividend Rate 0.48 | Beta 0.51 |
Basic technical analysis of Phibro Stock
As of the 28th of November, Phibro Animal holds the Coefficient Of Variation of 1096.4, risk adjusted performance of 0.0764, and Semi Deviation of 1.72. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phibro Animal, as well as the relationship between them.Phibro Animal's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phibro Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Corcoran E Thomas over two months ago Acquisition by Corcoran E Thomas of 5000 shares of Phibro Animal at 20.02 subject to Rule 16b-3 | ||
Daniel Bendheim over six months ago Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 11.83 subject to Rule 16b-3 | ||
Larry Miller over a year ago Acquisition by Larry Miller of 300000 shares of Phibro Animal subject to Rule 16b-3 |
Phibro Animal's Outstanding Corporate Bonds
Phibro Animal issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Phibro Animal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Phibro bonds can be classified according to their maturity, which is the date when Phibro Animal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Phibro Animal's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Phibro Animal's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0764 | |||
| Market Risk Adjusted Performance | 0.1427 | |||
| Mean Deviation | 1.82 | |||
| Semi Deviation | 1.72 | |||
| Downside Deviation | 1.91 | |||
| Coefficient Of Variation | 1096.4 | |||
| Standard Deviation | 2.31 | |||
| Variance | 5.33 | |||
| Information Ratio | 0.0347 | |||
| Jensen Alpha | 0.0186 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0419 | |||
| Treynor Ratio | 0.1327 | |||
| Maximum Drawdown | 9.05 | |||
| Value At Risk | (2.45) | |||
| Potential Upside | 3.86 | |||
| Downside Variance | 3.66 | |||
| Semi Variance | 2.95 | |||
| Expected Short fall | (2.08) | |||
| Skewness | 0.6215 | |||
| Kurtosis | 0.5708 |
| Risk Adjusted Performance | 0.0764 | |||
| Market Risk Adjusted Performance | 0.1427 | |||
| Mean Deviation | 1.82 | |||
| Semi Deviation | 1.72 | |||
| Downside Deviation | 1.91 | |||
| Coefficient Of Variation | 1096.4 | |||
| Standard Deviation | 2.31 | |||
| Variance | 5.33 | |||
| Information Ratio | 0.0347 | |||
| Jensen Alpha | 0.0186 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0419 | |||
| Treynor Ratio | 0.1327 | |||
| Maximum Drawdown | 9.05 | |||
| Value At Risk | (2.45) | |||
| Potential Upside | 3.86 | |||
| Downside Variance | 3.66 | |||
| Semi Variance | 2.95 | |||
| Expected Short fall | (2.08) | |||
| Skewness | 0.6215 | |||
| Kurtosis | 0.5708 |
Consider Phibro Animal's intraday indicators
Phibro Animal intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Phibro Animal stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Phibro Animal Corporate Filings
F3 | 15th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Phibro Stock media impact
Far too much social signal, news, headlines, and media speculation about Phibro Animal that are available to investors today. That information is available publicly through Phibro media outlets and privately through word of mouth or via Phibro internal channels. However, regardless of the origin, that massive amount of Phibro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phibro Animal news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phibro Animal relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phibro Animal's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phibro Animal alpha.
Phibro Animal Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Phibro Animal can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Phibro Animal's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.